Amphion Innovations plc

Annual General Meeting Results

London and New York, 7 August 2015 - Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today announces that all resolutions were passed at the Annual General Meeting, which was held on Friday 7 August 2015. 

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Yellow Jersey PR
Dominic Barretto / Philip Ranger/ Fiona Walker
+44 7768 537 739

Panmure Gordon Limited (Nominated Advisor and Joint Corporate Broker)
Freddy Crossley / Fred Walsh (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500

Northland Capital Partners Limited (Joint Corporate Broker)
Gerry Beaney/ David Hignell (Corporate Finance)
John Howes/ Mark Treharne (Corporate Broking)
+44 020 7382 1100

Plumtree Capital Limited (Advisor to Amphion)
Stephen Austin
+44 020 7183 2493
+646 568 7502

About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and technology businesses.

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: